Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract

Cell Carcinoma ◽

Transitional Cell ◽

Line Treatment ◽

First Line ◽

UP-03.139 Endoscopic Laser Therapy as First-Line Treatment for Upper Urinary Tract Transitional Cell Carcinoma Smaller Than Two Centimeters

Urology ◽

10.1016/j.urology.2011.07.1228 ◽

2011 ◽

Vol 78 (3) ◽

pp. S389

Author(s):

E. Beels ◽

F. Van Der Aa ◽

B. Van Cleynenbreugel ◽

S. Joniau

Keyword(s):

Urinary Tract ◽

Cell Carcinoma ◽

Transitional Cell ◽

Upper Urinary Tract ◽

Line Treatment ◽

First Line ◽

Endoscopic Laser ◽

Endoscopic Laser Therapy ◽

A phase II trial of pemetrexed plus gemcitabine as first-line treatment for locally advanced or metastatic transitional cell carcinoma of the urothelium

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4592 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4592-4592 ◽

Cited By ~ 1

Author(s):

H. von der Maase ◽

J. Lehmann ◽

G. Gravis ◽

H. Joensuu ◽

B. Bihn ◽

...

Keyword(s):

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Transitional Cell ◽

Line Treatment ◽

First Line ◽

Phase II study of MTX-HSA in combination with Cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma

Investigational New Drugs ◽

10.1007/s10637-006-8221-6 ◽

2006 ◽

Vol 24 (6) ◽

pp. 521-527 ◽

Cited By ~ 46

Author(s):

C. Bolling ◽

T. Graefe ◽

C. Lübbing ◽

F. Jankevicius ◽

S. Uktveris ◽

...

Keyword(s):

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Transitional Cell ◽

Line Treatment ◽

First Line ◽

Gemcitabine or Gemcitabine Plus Oxaliplatin in the First-Line Treatment of Patients With Advanced Transitional Cell Carcinoma of the Urothelium Unfit for Cisplatin-Based Chemotherapy: A Randomized Phase 2 Study of the French Genitourinary Tumor Group (GETUG V01)

European Urology ◽

10.1016/j.eururo.2011.08.072 ◽

2011 ◽

Vol 60 (6) ◽

pp. 1251-1257 ◽

Cited By ~ 22

Author(s):

Stéphane Culine ◽

Aude Fléchon ◽

Aline Guillot ◽

Sylvestre Le Moulec ◽

Damien Pouessel ◽

...

Keyword(s):

Cell Carcinoma ◽

Transitional Cell ◽

Line Treatment ◽

Phase 2 ◽

First Line ◽

Tumor Group ◽

Phase 2 Study ◽

Randomized Phase 2 ◽

Randomized Phase III Trial of Piroxicam in Combination with Mitoxantrone or Carboplatin for First-Line Treatment of Urogenital Tract Transitional Cell Carcinoma in Dogs

Journal of Veterinary Internal Medicine ◽

10.1111/jvim.12533 ◽

2015 ◽

Vol 29 (1) ◽

pp. 261-267 ◽

Cited By ~ 26

Author(s):

S.D. Allstadt ◽

C.O. Rodriguez ◽

B. Boostrom ◽

R.B. Rebhun ◽

K.A. Skorupski

Keyword(s):

Cell Carcinoma ◽

Transitional Cell ◽

Urogenital Tract ◽

Phase Iii ◽

Line Treatment ◽

First Line ◽

Phase Iii Trial ◽

410: A Comparative Study of the Oncological Long-Term Outcome of Laparoscopic Nephroureterectomy and Standard Nephroureterectomy for Upper Urinary Tract Transitional Cell Carcinoma

10.1016/s0022-5347(18)30663-3 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 136-137

Author(s):

Yasuyuki Kobayashi ◽

Takashi Saika ◽

Daisuke Manabe ◽

Shin Ebara ◽

Yasutomo Nasu ◽

...

Keyword(s):

Urinary Tract ◽

Comparative Study ◽

Cell Carcinoma ◽

Transitional Cell ◽

Upper Urinary Tract ◽

Term Outcome ◽

Long Term Outcome ◽

Laparoscopic Nephroureterectomy

408: Prognostic Value of Lymphnode Dissection in Patients with Muscle-Invasive Transitional Cell Carcinoma of the Upper Urinary Tract

10.1016/s0022-5347(18)30661-x ◽

2007 ◽

Vol 177 (4S) ◽

pp. 136-136

Author(s):

Marco Roscigno ◽

Cesare Cozzarini ◽

Roberto Bertini ◽

Vincenzo Scattoni ◽

Alessandra Pastal ◽

...

Keyword(s):

Urinary Tract ◽

Invasive Transitional Cell Carcinoma

Cell Carcinoma ◽

Prognostic Value ◽

Transitional Cell ◽

Upper Urinary Tract ◽

Muscle Invasive ◽

998: Lymphov Ascular Invasion Independently Predicts Decreased Disease Specific Survival in Patients with Transitional Cell Carcinoma of the Upper Urinary Tract

10.1016/s0022-5347(18)35154-1 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 270-270

Author(s):

Eiji Kikuchi ◽

Yutaka Horiguchi ◽

Naoki Hatakeyama ◽

Mayuko Matsumoto ◽

Toru Nishiyama ◽

...

Keyword(s):

Urinary Tract ◽

Cell Carcinoma ◽

Transitional Cell ◽

Upper Urinary Tract ◽

Disease Specific Survival ◽

Disease Specific

842: Low Efficacy of Intravesical BCG Immunotherapy in Elderly Patients with Intermediate-High Risk Ta-T1 Transitional Cell Carcinoma (TCC) of the Bladder: Long Term Experience of a Single Institution

10.1016/s0022-5347(18)33078-7 ◽

2006 ◽

Vol 175 (4S) ◽

pp. 271-272 ◽

Cited By ~ 1

Author(s):

Giorgio Verrini ◽

Maurizio Brausi ◽

Mirko Gavioli ◽

Giuseppe De Luca ◽

Giancarlo Peracchia ◽

...

Keyword(s):

High Risk ◽

Elderly Patients ◽

Cell Carcinoma ◽

Transitional Cell ◽

Single Institution ◽

Bcg Immunotherapy ◽

Intravesical Bcg ◽

Long Term Experience

FDA approves pembrolizumab for first-line treatment of head and neck squamous cell carcinoma

Case Medical Research ◽

10.31525/cmr-14e3317 ◽

2019 ◽

Author(s):

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Neck Squamous Cell Carcinoma ◽

Line Treatment ◽

First Line ◽